Recludix Pharma
Latest round
- Series A
Last raised
- Nov 2021
Total raised
- $60M
Investors
- 3
About Recludix Pharma
Founded in 2019 in San Diego, US, Recludix Pharma, Inc. specializes in developing therapeutics for inflammatory conditions.Recludix Pharma specializes in developing innovative therapeutics aimed at improving the lives of patients suffering from inflammatory diseases. The company focuses on biologically-validated targets, particularly those associated with SH2 domains, which play a critical role in regulating protein activities and mediating intracellular signaling. Through its research and development efforts, Recludix aims to create transformative medicines that address the underlying mechanisms of various inflammatory conditions. The company's products are designed for healthcare providers and ultimately serve patients who require advanced treatments for chronic inflammatory diseases.Recludix Pharma generates revenue through strategic partnerships and collaborations with pharmaceutical companies and research institutions, focusing on the co-development and commercialization of its therapeutic products. The company engages in B2B transactions, providing access to its proprietary technologies and therapeutic candidates for further development. Revenue structures may involve milestone payments, royalties, and co-marketing agreements, which facilitate a steady influx of capital as products advance through clinical trials and gain regulatory approval. The company is focused on designing and launching new products aimed at treating inflammatory diseases, though specific release dates are not disclosed. Additionally, Recludix is targeting expansion into emerging markets within North America and Europe to enhance patient access to its therapies.
Who invested in Recludix Pharma
3 investors across 1 round
See all investors in Recludix Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 15, 2021
Amount
$60M
Investors
Questions about Recludix Pharma
Who invested in Recludix Pharma?
Recludix Pharma has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Recludix Pharma raised?
Recludix Pharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Recludix Pharma last raise money?
Recludix Pharma's most recent round on record is a Series A, in Nov 2021.
What does Recludix Pharma do?
Founded in 2019 in San Diego, US, Recludix Pharma, Inc.
Where is Recludix Pharma headquartered?
Recludix Pharma is headquartered in San Diego, US.
Which VCs invest in companies like Recludix Pharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Recludix Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Recludix Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.